000 01459 a2200433 4500
005 20250516115526.0
264 0 _c20140123
008 201401s 0 0 eng d
022 _a1989-4600
024 7 _a10.1016/j.rpsm.2012.05.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPons i Villanueva, Alexandre
245 0 0 _aShould obesity be a limiting factor for clozapine treatment?
_h[electronic resource]
260 _bRevista de psiquiatria y salud mental
_c
300 _a75-9 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBody Mass Index
650 0 4 _aClozapine
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aObesity
_xcomplications
650 0 4 _aRegression Analysis
650 0 4 _aRetrospective Studies
650 0 4 _aSchizophrenia
_xcomplications
650 0 4 _aTreatment Outcome
650 0 4 _aWeight Gain
_xdrug effects
700 1 _aRomero, Anna
700 1 _aGoti, Javier
700 1 _aFernandez-Egea, Emilio
700 1 _aUndurraga, Juan
700 1 _aCarne, Xavier
700 1 _aBernardo, Miquel
773 0 _tRevista de psiquiatria y salud mental
_gvol. 6
_gno. 2
_gp. 75-9
856 4 0 _uhttps://doi.org/10.1016/j.rpsm.2012.05.005
_zAvailable from publisher's website
999 _c22200104
_d22200104